Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancer.
Saved in:
| Title: | Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancer. |
|---|---|
| Authors: | Hori C; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Molecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Kumegawa K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan. kohei.kumegawa@jfcr.or.jp., Saeki S; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Takahashi Y; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Yang L; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Nakadai T; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Otsuji K; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan., Takahata C; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Ozaki Y; Breast Medical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Uehiro N; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Haruyama Y; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Osako T; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Takano T; Breast Medical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Mori S; Division of Cancer Genomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan., Noda T; Director's Room, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Fujii S; Department of Molecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan., Ohno S; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Ueno T; Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Maruyama R; Division of Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. reo.maruyama@jfcr.or.jp.; Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research, Tokyo, Japan. reo.maruyama@jfcr.or.jp. |
| Source: | Genome medicine [Genome Med] 2025 Nov 27; Vol. 17 (1), pp. 145. Date of Electronic Publication: 2025 Nov 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
